Indivior Pharmaceuticals, Inc. (INDV) — Operating Income

Annual figures by fiscal year, from SEC filings.

2022: -$81.00M2023: -$152.00M2024: $38.00M2025: $262.00M$262.00M
2022Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025$262.00M+589.5%
2024$38.00M+125.0%
2023-$152.00M-87.7%
2022-$81.00M